Eisner Mark
EVP and Chief Medical Officer
Eisner Mark has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Feb 26, 2026.
On the most recent filing, Eisner Mark is listed as EVP and Chief Medical Officer at Vir Biotechnology, Inc. Inside the rolling window, Eisner Mark reported no open-market purchases and 3 open-market sales totaling $50K in VIR. The largest disclosed transaction in the window is a sale of 1,889 VIR shares on Feb 25, 2026, worth $19K.
Companies traded
Other insiders at VIR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$50K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Eisner Mark made?
Eisner Mark has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Eisner Mark trade?
Eisner Mark has filed SEC Form 4 disclosures for 1 company, including VIR.
When was Eisner Mark's most recent SEC Form 4 filing?
Eisner Mark's most recent SEC Form 4 filing on Tracefour is dated Feb 26, 2026.
What is Eisner Mark's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Eisner Mark is listed as EVP and Chief Medical Officer.
What is Eisner Mark's total buy and sell value in the current window?
Inside the rolling retention window, Eisner Mark bought $0 and sold $50K based on SEC Form 4 filings.
What was Eisner Mark's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,889 VIR shares on 2026-02-25, worth $19K, per SEC Form 4 filings.